» Authors » Marta Altieri

Marta Altieri

Explore the profile of Marta Altieri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 427
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Giuliani G, Costa D, Pellicano C, Gargiulo P, Virili C, Di Piero V, et al.
Headache . 2025 Mar; PMID: 40079729
Objective: To investigate the characteristics and nature of headache in a population of patients with acromegaly. Background: Headache is frequently described by patients with pituitary adenomas. Although it is mainly...
2.
Vigano A, Petolicchio B, Toscano M, Ruggero S, Di Giambattista R, Puma M, et al.
Neurol Sci . 2025 Mar; PMID: 40048115
Introduction: Among non-pharmacological approach for chronic migraine (CM), Short-Term Psychodynamic Psychotherapy (STPP) is suggested in CM and, particularly, in interrupting medication overuse (MO). In this study, we aim at identifying...
3.
Stadio A, Ralli M, De Luca P, Sossamon J, Frohman T, Altieri M, et al.
Front Neurol . 2024 Oct; 15:1443591. PMID: 39359872
Background: Facial synkinesis (FS) is a distressing sequela of facial palsy (FP) characterized by involuntary, simultaneous movements of facial muscles occurring during voluntary facial expressions. Treatment of synkinesis is challenging,...
4.
DAmbrosio A, Zamboni S, Camerini S, Casella M, Sanchez M, Pietraforte D, et al.
J Neuroinflammation . 2024 Sep; 21(1):217. PMID: 39223661
Background And Objectives: There is an urgent need to discover blood-based biomarkers of multiple sclerosis (MS) to better define the underlying biology of relapses and monitor disease progression. The main...
5.
Giuliani G, Zilli C, Caramia F, Di Piero V, Altieri M
Mult Scler . 2024 Mar; 30(9):1227-1229. PMID: 38426436
Background: Facial pain in multiple sclerosis is often due to trigeminal neuralgia but atypical pictures can be observed. Case Presentation: A man with primary progressive multiple sclerosis developed severe unilateral...
6.
Ruggieri S, Ianniello A, Copetti M, Altieri M, Buscarinu M, Centonze D, et al.
Neurotherapeutics . 2024 Feb; 21(3):e00338. PMID: 38413275
Despite its widespread use in clinical practice, the effectiveness of natalizumab extended interval dosing (EID) adopted from treatment start across different treatment intervals and individual modifiers (body mass index -...
7.
Stadio A, De Luca P, Koohi N, Kaski D, Ralli M, Giesemann A, et al.
Front Neurol . 2023 Sep; 14:1204132. PMID: 37662038
Background: Hearing can be impaired in many neurological conditions and can even represent a forme of specific disorders. Auditory function can be measured by either subjective or objective tests. Objective...
8.
Zilli C, Scribani Rossi P, Stadio A, Fratino M, Giuliani G, Annecca R, et al.
Front Neurol . 2023 Aug; 14:1187851. PMID: 37609659
Introduction: Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS with an autoimmune pathogenesis. Over the years, numerous disease-modifying therapies (DMTs) have proven effective in disease control;...
9.
Giuliani G, Gorgoni M, Altieri M, Di Piero V
Front Neurol . 2023 Aug; 14:1230710. PMID: 37564733
Introduction: Cluster headache (CH) is a trigeminal autonomic cephalalgia characterized by attacks of severe unilateral pain associated with ipsilateral autonomic symptoms. Cluster headache attacks exhibit nocturnal predilection, and sleep disorders...
10.
Maestrini I, Rocchi L, Puledda F, Vigano A, Giuliani G, Jannini T, et al.
Front Neurol . 2023 Mar; 14:1072785. PMID: 36970542
Objectives: Migraine is one of the most frequent clinical manifestations of hypermobile Ehlers-Danlos syndrome (hEDS). The comorbidity between these two diseases has been only partially investigated. We aimed to observe...